Antibody Target Predictor

Patsnap’s Antibody Target Predictor simplifies the traditionally time-consuming task of identifying and validating antibody-target relationships by combining data such as antibody-antigen pairings, epitope details, and affinity into clear, evidence-based recommendations. With a simple prompt, users can generate a structured report that breaks down the agent’s reasoning alongside detailed results, including summaries of analyzed antibodies, the latest developments from patent literature, and detailed insight into affinity and performance. The output goes further by ranking top candidates with supporting rationale, helping users quickly understand why certain antibodies stand out. It all culminates in practical, actionable insights for research, therapeutic, or diagnostic applications, with easy options to share or download the report for broader collaboration

• The Antibody Target Predictor is part of Patsnap’s Life Science AI suite.
  
  It is designed to help with the labor-intensive task of validating and screening antibody-target relationships.
  
  The tool combines multiple data types, including:
  
  Antibody-antigen pairings
  
  Epitope information
  
  Affinity data
  
  Other supporting evidence
  
  Goal: quickly generate evidence-based antibody recommendations for a target.
• Use the prompt interface in the middle of the screen.
  
  You can start from the built-in example prompts below the interface.
  
  In the demo, the prompt used is:
  
  Find the optimal antibodies for the tau target
• After entering your prompt, click the blue arrow to run it.
  
  The agent begins processing the request.
  
  The interface is organized into two main areas:
  
  Left side: the agent’s thinking/process breakdown
  
  Right side: the generated report
• Once processing is complete, the report presents a structured, evidence-based output.
  
  The agent compiles information such as:
  
  Affinity characteristics
  
  Binding kinetics
  
  Epitope information
  
  Other relevant antibody data
  
  This supports tau antibody selection with a data-backed recommendation.
• The report begins with a summary section.
  
  This section shows:
  
  How many antibodies were evaluated
  
  The main focus areas used in the analysis
  
  Use this section to quickly understand the scope and purpose of the report.
• The next section lists the top five latest tau antibodies from recent patent publications.
  
  Each entry includes:
  
  Links to the relevant patents
  
  Heavy chain sequences
  
  Light chain sequences
  
  This is useful for tracking recent developments in the field.
• Section 3 focuses on affinity characteristics and performance.
  
  It ranks the top five antibodies by affinity.
  
  This includes:
  
  Patent information
  
  Heavy and light chain sequences
  
  Performance values such as KD and affinity data
• Section 4 provides a comprehensive ranking of recommended antibodies.
  
  This ranking combines:
  
  KD and affinity data
  
  Additional performance indicators such as EC50 data
  
  The chart is followed by selection rationale, which explains why the antibodies were ranked that way.
• The final section summarizes the main findings of the report.
  
  It also provides practical recommendations for:
  
  Research use
  
  Therapeutic development
  
  Diagnostic applications
  
  This helps turn the report into actionable insights.
• If you want to share the report with colleagues, use the blue Share button on the left.
  
  You can also download the report as a Word document for external analysis or sharing.